{"abstract":"The Food and Drug Administration (FDA or the Agency) is announcing the availability of a draft guidance entitled \"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act.\" The draft guidance describes FDA's interim regulatory policy regarding outsourcing facilities that compound human drug products using bulk drug substances while FDA develops the list of bulk drug substances that can be used in compounding under the Federal Food, Drug, and Cosmetic Act (the FD&C Act). When final, the guidance will reflect the Agency's current thinking on the issues addressed by the guidance.","action":"Notice of availability.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2015/10/27/2015-27268.html","cfr_references":[],"citation":"80 FR 65768","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance, submit either electronic or written comments on the draft guidance by December 28, 2015.","disposition_notes":null,"docket_ids":["Docket No. FDA-2015-D-3539"],"dockets":[],"document_number":"2015-27268","effective_on":null,"end_page":65769,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2015/10/27/2015-27268.xml","html_url":"https://www.federalregister.gov/documents/2015/10/27/2015-27268/interim-policy-on-compounding-using-bulk-drug-substances-under-section-503b-of-the-federal-food-drug","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2015-27268?publication_date=2015-10-27","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2015-10-27/2015-27268/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":517,"last_updated":"2026-11-22 08:15:04 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2015-10-27/pdf/2015-27268.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2015-27268.pdf?1445863617","publication_date":"2015-10-27","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2015/10/27/2015-27268.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2015-D-3539","supporting_documents_count":0,"docket_id":"FDA-2015-D-3539","regulation_id_number":null,"title":"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act","checked_regulationsdotgov_at":"2015-12-29T05:00:43Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":65768,"subtype":null,"title":"Interim Policy on Compounding Using Bulk Drug Substances Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability","toc_doc":"Interim Policy on Compounding Using Bulk Drug Substances under the Federal Food, Drug, and Cosmetic Act","toc_subject":"Guidance:","topics":[],"type":"Notice","volume":80}